GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of unpopular opinion: most of what gets said here about MHRA is guesswork — 30 comments in the full submission. View in context.
536
c/glp1uk·submitted 1 year ago by u/camila_sandvik

unpopular opinion: most of what gets said here about MHRA is guesswork

Discussionbranch of 7 comments

Posting this as a discussion rather than a claim: unpopular opinion: most of what gets said here about MHRA is guesswork. Discharged at goal back to the GP, who would not continue it. Nobody had mentioned that this was how it ends. GP said no in the spring, specialist said yes eighteen months later. Same person, same…

Read the full submission and all 30 comments →

This branch

7 comments, started 1 year ago
u/viktor_kirchner85 points·1 year ago

Supply notices from the regulator describe expected availability at a national level. They do not predict what any individual pharmacy has on the shelf next week.

replysharereportpermalink
[deleted]63 points·1 year ago

[deleted]

replysharereportpermalink
u/rina_nascimento37 points·1 year ago

Same. My ICB threshold was different from the neighbouring one and nobody could tell me why.

replysharereportpermalink
u/emil_okwuosa13 points·1 year ago

A private prescription is an independent route: it does not affect NHS list position, and it is not a step in the same pathway.

replysharereportpermalink
u/marit_coelho4 points·1 year ago

Discharge from a specialist service at goal is a normal end point of that pathway. Whether prescribing continues in primary care afterwards is a local decision and is worth asking about at the start rather than at the end.

replysharereportpermalink
u/marit_mensa46 points·1 year ago

England, Scotland, Wales and Northern Ireland are four different pathways

replysharereportpermalink
u/ipamorelin_i15 points·1 year ago

the Irish scheme cap is the single most useful fact in this board

replysharereportpermalink

← back to the whole thread

About c/glp1uk

UK-specific access: NHS tier-3 and specialist weight-management pathways, the two-year waiting-list reality, private prescription routes and their monthly cost, pharmacy stock, MHRA supply notices, and how the UK rules differ from the US conversation that dominates most of the internet.

43kmembers
95submissions
Jan 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1uk rules
  1. No naming online pharmacies that prescribe without a consultation.
  2. Price posts need the date — UK private pricing moves monthly.
  3. NHS pathway questions: say which nation. England, Scotland, Wales and NI differ.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.